Large-scale testing (Phase 3)Study completedNCT03379727
What this trial is testing
Study to Assess the Safety and Efficacy of Midostaurin (PKC412) in Combination With Standard Chemotherapy During Induction and Consolidation Followed by 12 Months of Maintenance Monotherapy in Patients With Newly-diagnosed FMS-like Tyrosine 3 (FLT3) Kinase Receptor-mutated Acute Myeloid Leukemia.
Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 301